Navigation Links
TRICAST Launches New Version of Web-Based Pharmacy Benefits Surveillance and Analytics Software Tool
Date:8/14/2014

MILWAUKEE, Aug. 14, 2014 /PRNewswire/ -- TRICAST, Inc. today announced the availability of Reveal™ 2.0, its cutting-edge web-based software tool that leverages nearly two decades' worth of prescription drug benefit consulting expertise.

"We've baked all our knowledge into a product that delivers real-time surveillance and analytics (both retrospective and predictive) for comprehensive pharmacy benefit oversight. There's really nothing else like it in our industry," said TRICAST President Greg Rucinski.

The release of Reveal also marks TRICAST's entry into the software as a service (SaaS) market space. SaaS is a software and licensing delivery model in which the software is licensed on a subscription basis and is centrally hosted.

"Applying a SaaS model in the healthcare industry has the potential to significantly reduce our client's IT support costs as well as allowing Reveal™ to grow with the client without incurring additional IT capital expenditures," noted Director of Infrastructure Chris Favero.

Reveal enables TRICAST clients to monitor pricing, process, and formulary and rebate adherence. The tool also includes a full suite of Centers for Medicare & Medicaid Services (CMS) oversight products such as automated reject analysis, comparisons of source to PDE claims, and all other CMS oversight requirements.

"We've learned a lot about what's important to the healthcare marketplace in our two decades of consulting and we've built it into Reveal," said Director of Software Development Ken Ullsperger.

For example, many need an automated method of importing data that's integrated with fixed files such as Medi-Span® or First DataBank® pharmaceutical information, CMS watch list criteria, CMS gap discount information, taxonomy files, and other decision-support information.

"We want to be very clear: TRICAST is not abandoning our tried and true consulting offerings. What it really means is that we are empowering our clients by harnessing the benefits of our fifteen years of experience and making it available to them," concluded Rucinski. "Our Reveal clients benefit because their pharmacy benefit data is available for comparative analysis at a daily, hourly and even down to the minute frequency. Our Reveal clients can now focus on the road ahead instead of looking back at what has already transpired."

About TRICAST

TRICAST is a pharmacy data analytics company utilizing industry expertise and powerful software tools to empower our clients to make decisions that lower their healthcare costs and efficiently manage their pharmacy benefit programs. TRICAST is headquartered in Milwaukee, Wisconsin. We serve clients nationwide.

Media Contact

Rob Shelley, Senior VP of Business Development
612-940-6390
Email


'/>"/>
SOURCE TRICAST
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. TRICAST Announces Patent-Pending Technology for Real-Time Health Data Analysis
2. TRICAST Hosts Annual Round Table Assessment of Mid-Market Pharmacy Benefit Managers, Specialty Providers
3. TRICAST Debuts Part D Rejection Oversight Solution for Drug Plan Sponsors
4. Marijuana Connect Launches in the Spectacular Summer of 2014!
5. NCPA Launches Any Willing Pharmacy Campaign During August Congressional Recess
6. Z Trim Launches Food-Grade Biofiber Gum
7. OSTAR Launches Its A Series Cloud Based Telehealth Vital Signs Patient Monitoring System
8. Janssen Launches Online Healthy Minds Video Series
9. AARC Launches Virtual Museum
10. CPhI South America 2014 Launches with Generics Showing Huge Growth
11. Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... One of Australia,s successful biotechnology scientists, Dr ... biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm ... on the ASX. Noxopharm is a clinic-ready company with ... 1 clinical study later this year. ... problems facing cancer patients - the ability of cancers to become ...
(Date:6/26/2016)... DUBLIN , June 27, 2016 Jazz ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... proposed acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... 11:59 p.m. (Eastern Daylight Time). As previously ... entered into a definitive merger agreement under which Jazz ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... 2016 , ... The OSHA Training Center at Chabot-Las ... headquartered in Northern California, has issued an important reminder to employers to prevent ... Employers with workers exposed to high temperatures should establish a complete heat illness ...
(Date:6/27/2016)... ... ... "FCPX editors can now reveal their media with growing colorful split screen ... - CEO of Pixel Film Studios. , ProSlice Color brings the split screens ... reveal the media of their split screens with growing colorful panels. , ProSlice Color ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... health professionals, announced today its affiliation with Tennessee Counseling Association. This ... the network of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... today announced its strategic partnership with Connance, a healthcare industry leader providing ... companies’ proven, proprietary technology combine to provide health systems, hospitals and ambulatory ...
(Date:6/27/2016)... , ... June 27, 2016 , ... ... edge technology to revolutionize the emergency ambulance transport experience for the millions of ... of how Uber has disrupted the taxi industry through the use of technology. ...
Breaking Medicine News(10 mins):